Jochen Greiner

3.7k total citations
92 papers, 2.7k citations indexed

About

Jochen Greiner is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Jochen Greiner has authored 92 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 42 papers in Hematology and 34 papers in Oncology. Recurrent topics in Jochen Greiner's work include Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (26 papers) and Acute Myeloid Leukemia Research (22 papers). Jochen Greiner is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (26 papers) and Acute Myeloid Leukemia Research (22 papers). Jochen Greiner collaborates with scholars based in Germany, United States and Switzerland. Jochen Greiner's co-authors include Michael Schmitt, Hartmut Döhner, Anita Schmitt, Mark Ringhoffer, Krzysztof Giannopoulos, Markus Wiesneth, Marlies Götz, Donald Bunjes, Markus Rojewski and Susanne Hofmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jochen Greiner

92 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Greiner Germany 27 1.4k 1.1k 984 871 322 92 2.7k
Mark Ringhoffer Germany 25 2.3k 1.6× 1.2k 1.1× 1.3k 1.3× 518 0.6× 204 0.6× 53 3.2k
Andreas Petzer Austria 26 879 0.6× 946 0.9× 977 1.0× 1.8k 2.0× 830 2.6× 111 3.3k
Yoshikane Kikushige Japan 25 1.1k 0.8× 755 0.7× 887 0.9× 1.0k 1.2× 426 1.3× 89 2.5k
Wayne R. Godfrey United States 18 1.8k 1.3× 1.4k 1.2× 1.0k 1.0× 433 0.5× 628 2.0× 45 3.6k
Tessa Kerre Belgium 26 940 0.7× 769 0.7× 670 0.7× 427 0.5× 170 0.5× 112 2.1k
Bertrand Huard Switzerland 33 3.3k 2.3× 1.7k 1.5× 630 0.6× 534 0.6× 211 0.7× 68 4.5k
Andries C. Bloem Netherlands 23 709 0.5× 628 0.6× 706 0.7× 792 0.9× 226 0.7× 57 1.9k
Marion Kleijer Netherlands 26 1.6k 1.2× 453 0.4× 979 1.0× 606 0.7× 393 1.2× 50 3.1k
Kaoru Uchimaru Japan 27 1.7k 1.2× 674 0.6× 818 0.8× 786 0.9× 335 1.0× 138 3.3k
Monica Doedens Canada 20 958 0.7× 827 0.8× 1.3k 1.4× 1.7k 1.9× 736 2.3× 28 3.2k

Countries citing papers authored by Jochen Greiner

Since Specialization
Citations

This map shows the geographic impact of Jochen Greiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Greiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Greiner more than expected).

Fields of papers citing papers by Jochen Greiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Greiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Greiner. The network helps show where Jochen Greiner may publish in the future.

Co-authorship network of co-authors of Jochen Greiner

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Greiner. A scholar is included among the top collaborators of Jochen Greiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Greiner. Jochen Greiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greiner, Jochen, et al.. (2024). Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia. Cancers. 16(20). 3443–3443. 2 indexed citations
2.
Guinn, Barbara‐ann, Patrick J. Schuler, Hubert Schrezenmeier, et al.. (2023). A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 24(11). 9285–9285. 4 indexed citations
3.
Greiner, Jochen, Patrick J. Schuler, Susanne Hofmann, et al.. (2022). Enhanced stimulation of antigen‐specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti‐programmed death 1 antibody. British Journal of Haematology. 198(5). 866–874. 12 indexed citations
4.
Greiner, Jochen, Marlies Götz, & Verena Wais. (2022). Increasing Role of Targeted Immunotherapies in the Treatment of AML. International Journal of Molecular Sciences. 23(6). 3304–3304. 14 indexed citations
5.
Greiner, Jochen, Lars Bullinger, Robert K. Hills, et al.. (2021). Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients. International Journal of Molecular Sciences. 22(19). 10482–10482. 7 indexed citations
6.
Greiner, Jochen, Stephanie von Harsdorf, Roland Moll, et al.. (2021). Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma. Blood Advances. 5(19). 3789–3793. 16 indexed citations
7.
Greiner, Jochen, Marlies Götz, Constanze Wendt, et al.. (2020). Characteristics and mechanisms to control a COVID‐19 outbreak on a leukemia and stem cell transplantation unit. Cancer Medicine. 10(1). 237–246. 4 indexed citations
8.
Greiner, Jochen, Marlies Götz, Susanne Hofmann, et al.. (2020). Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition. Cancer Immunology Immunotherapy. 69(4). 629–640. 12 indexed citations
9.
Götz, Marlies, Jochen Greiner, Simon Laban, et al.. (2020). Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy. International Journal of Molecular Sciences. 21(15). 5181–5181. 22 indexed citations
10.
Greiner, Jochen, Marlies Götz, Donald Bunjes, Susanne Hofmann, & Verena Wais. (2019). Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients. Journal of Clinical Medicine. 9(1). 39–39. 20 indexed citations
11.
Hofmann, Susanne, Michael Schmitt, Marlies Götz, et al.. (2018). Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders. International Journal of Cancer. 144(5). 1135–1146. 10 indexed citations
12.
Bullinger, Lars, Richard F. Schlenk, Marlies Götz, et al.. (2013). PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17). Clinical Cancer Research. 19(9). 2562–2571. 31 indexed citations
13.
Graux, Carlos, Anne Sonet, Johan Maertens, et al.. (2013). A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. Leukemia Research. 37(9). 1100–1106. 18 indexed citations
14.
Heinz, Werner, Gerlinde Egerer, Heinrich Lellek, Angelika Boehme, & Jochen Greiner. (2012). Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis. Mycoses. 56(3). 304–310. 40 indexed citations
15.
Hofmann, Susanne & Jochen Greiner. (2011). Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine. Transfusion Medicine and Hemotherapy. 38(3). 4–4. 4 indexed citations
16.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2010). Effects of nilotinib on regulatory T cells: the dose matters. Molecular Cancer. 9(1). 22–22. 22 indexed citations
17.
18.
Schmitt, Anita, Li Li, Krzysztof Giannopoulos, et al.. (2008). Quantitative expression of Toll‐like receptor‐2, ‐4, and ‐9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Transfusion. 48(5). 861–870. 19 indexed citations
19.
Greiner, Jochen & Michael Schmitt. (2008). Leukemia‐associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia. European Journal Of Haematology. 80(6). 461–468. 19 indexed citations
20.
Greiner, Jochen, Mark Ringhoffer, Masanori Taniguchi, et al.. (2003). mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. International Journal of Cancer. 108(5). 704–711. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Ringhoffer Breakdown of academic impact, for papers by Andreas Petzer Breakdown of academic impact, for papers by Yoshikane Kikushige Breakdown of academic impact, for papers by Wayne R. Godfrey Breakdown of academic impact, for papers by Tessa Kerre Breakdown of academic impact, for papers by Bertrand Huard Breakdown of academic impact, for papers by Andries C. Bloem Breakdown of academic impact, for papers by Marion Kleijer Breakdown of academic impact, for papers by Kaoru Uchimaru Breakdown of academic impact, for papers by Monica Doedens
Rankless by CCL
2026